These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 5671339)

  • 1. Effect of topical vehicle composition on the in vitro release of fluocinolone acetonide and its acetate ester.
    Poulsen BJ; Young E; Coquilla V; Katz M
    J Pharm Sci; 1968 Jun; 57(6):928-33. PubMed ID: 5671339
    [No Abstract]   [Full Text] [Related]  

  • 2. Significance of vehicle composition. I. Relationship between topical vehicle composition, skin penetrability, and clinical efficacy.
    Ostrenga J; Steinmetz C; Poulsen B
    J Pharm Sci; 1971 Aug; 60(8):1175-9. PubMed ID: 5127090
    [No Abstract]   [Full Text] [Related]  

  • 3. Development and evaluation of ointment and cream vehicles for a new topical steroid, fluclorolone acetonide.
    Malone T; Haleblian JK; Poulsen BJ; Burdick KH
    Br J Dermatol; 1974 Feb; 90(2):187-95. PubMed ID: 4819137
    [No Abstract]   [Full Text] [Related]  

  • 4. Fluocinonide--a new topical corticosteroid. Clinical evaluation.
    Mendelson CG
    Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):63-5. PubMed ID: 5291635
    [No Abstract]   [Full Text] [Related]  

  • 5. The quantitative determination of fluocinolone acetonide and acetonide acetate in formulated products by high pressure liquid chromatography.
    Bailey F; Brittain PN
    J Pharm Pharmacol; 1972 Jun; 24(6):425-8. PubMed ID: 4403822
    [No Abstract]   [Full Text] [Related]  

  • 6. [FLUOCINOLONE ACETONIDE IN PROPYLENE GLYCOL. SOME RESULTS IN DERMATOLOGIC THERAPY].
    PELFINI C
    Minerva Dermatol; 1965 Jun; 40():245-7. PubMed ID: 14346246
    [No Abstract]   [Full Text] [Related]  

  • 7. An improved method of assessing topical corticosteroid activity.
    Barnes H; Gaylarde PM; Brock AP; Sarkany I
    Br J Dermatol; 1975 Oct; 93(4):459-64. PubMed ID: 1201192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of the optimal topical system for fluocinonide.
    Reinstein J; Ostrenga J; Haleblian J; Shastri S; Poulsen B; Katz M
    Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):Suppl 67:13-8. PubMed ID: 5291642
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies on the stability of fluocinolone-acetenide in pharmaceutical preparations].
    Brode E
    Arzneimittelforschung; 1967 Jan; 17(1):103-8. PubMed ID: 5632520
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical experiments on the topical use of fluocinolone acetonide in propylene glycol].
    Vignali C
    Arcisp S Anna Ferrara; 1966; 19(4):535-40. PubMed ID: 5959876
    [No Abstract]   [Full Text] [Related]  

  • 11. [COMPARATIVE STUDIES ON THE TOPICAL TREATMENT OF ECZEMA WITH FLUOCINOLONE ACETONIDE AND 6-ALPHA-METHYLPREDNISOLONE ACETATE].
    BJOERNBERG A; HELLGREN L; MARTIN B
    Dermatol Wochenschr; 1964 Jul; 150():12-3. PubMed ID: 14252713
    [No Abstract]   [Full Text] [Related]  

  • 12. Penetration kinetics of four drugs in the human skin. Influences of various pharmaceutical vehicles on penetration in vitro.
    Zesch A; Schaefer H
    Acta Derm Venereol; 1974; 54(2):91-7. PubMed ID: 4133027
    [No Abstract]   [Full Text] [Related]  

  • 13. The evaluation of a novel corticosteroid formulation, fluocinonide in "FAPG" base, in the blanching test.
    Coldman MF; Lockerbie L; Laws EA
    Br J Dermatol; 1971 Dec; 85(6):573-6. PubMed ID: 4947552
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of formulation on the clinical response to topical fluocinolone acetonide.
    Portnoy B
    Br J Dermatol; 1965 Nov; 77(11):579-81. PubMed ID: 5853252
    [No Abstract]   [Full Text] [Related]  

  • 15. [Apropos of 30 cases treated by synalar ointment].
    Joseph JY
    J Med Lyon; 1967 Jun; 48(122):991. PubMed ID: 5613050
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of particle size and vehicle on the percutaneous absorption of fluocinolone acetonide.
    Barrett CW; Hadgraft JW; Caron GA; Sarkany I
    Br J Dermatol; 1965 Nov; 77(11):576-8. PubMed ID: 5853251
    [No Abstract]   [Full Text] [Related]  

  • 17. IMPROVED DERMATOLOGIC THERAPY WITH FLUOCINOLONE ACETONIDE, A NEW TOPICAL STEROID.
    FELDMAN I
    J Am Osteopath Assoc; 1963 Nov; 63():257-60. PubMed ID: 14059545
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical experience with fluocinonide in 90 out-patients.
    Eichenberger H
    Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):87. PubMed ID: 5291640
    [No Abstract]   [Full Text] [Related]  

  • 19. CLINICAL EVALUATION OF TOPICAL FLUOCINOLONE ACETONIDE OINTMENT.
    SCHER RK
    Curr Ther Res Clin Exp; 1963 Dec; 5():626-7. PubMed ID: 14084033
    [No Abstract]   [Full Text] [Related]  

  • 20. [TRIAMCINOLONE ACETONIDE AND FLUOCINOLONE IN TOPICAL USE WITH OCCLUSIVE BANDAGE].
    AYALA L
    Riforma Med; 1964 Feb; 78():203-4. PubMed ID: 14137199
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.